Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Human Embryonic Stem Cells Global Market Report 2025
Request Sample Buy Now
Global Human Embryonic Stem Cells Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Human Embryonic Stem Cells Global Market Report 2025

By Type (Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells), By Product (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Application (Research, Clinical Trials, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Human Embryonic Stem Cells Market Overview

• Human Embryonic Stem Cells market size has reached to $1.24 billion in 2024

• Expected to grow to $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Government Funding In Regenerative Medicine Is Propelling Growth Of Human Embryonic Stem Cells Market

• Market Trend: Expansion Into Diverse Therapeutic Applications To Advance Regenerative Medicines

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Embryonic Stem Cells Market?

Human embryonic stem cells (hESCs) are pluripotent cells derived from the inner cell mass of a blastocyst, an early-stage embryo. These cells have the unique ability to differentiate into any cell type in the human body, making them incredibly valuable for various research and therapeutic purposes. The primary uses of hESCs includes developing treatments for diseases and injuries by generating healthy tissue and studying the progression and treatment of diseases in a controlled environment.

The main types of human embryonic stem cells are totipotent stem cells, pluripotent stem cells, and unipotent stem cells. Totipotent stem cells have the unique ability to differentiate into any cell type found in an embryo as well as extra-embryonic tissues, such as the placenta. The product includes regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. The applications include research, clinical trials, and others.

Human Embryonic Stem Cells Market Size and growth rate 2025 to 2029: Graph

What Is The Human Embryonic Stem Cells Market Size 2025 And Growth Rate?

The human embryonic stem cells market size has grown rapidly in recent years. It will grow from $1.24 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to funding and investments, regulatory approvals, public awareness, the emergence of regenerative medicine, and expanded clinical applications.

What Is The Human Embryonic Stem Cells Market Growth Forecast?

The human embryonic stem cells market size is expected to see rapid growth in the next few years. It will grow to $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to an upsurge in several cell therapy production facilities, increasing demand for regenerative therapies, increasing incidence of cardiac and malignant diseases, advancements in stem cell biology research, and awareness about stem cell therapeutic potency. Major trends in the forecast period include advancements in regenerative medicine, increased focus on personalized medicine, growing applications in drug discovery and toxicology, technological innovations, and expansion in biobanking.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of regenerative therapies by inflating prices of stem cell cultivation materials and bioreactors developed in Sweden and Singapore, resulting in slowed research progress and higher biotech development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Human Embryonic Stem Cells Market Segmented?

1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells

2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing

3) By Application: Research, Clinical Trials, Other Applications

Subsegments:

1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells

2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells

3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells

What Is Driving The Human Embryonic Stem Cells Market? Government Funding In Regenerative Medicine Is Propelling Growth Of Human Embryonic Stem Cells Market

The government funding for the development of regenerative medicine is expected to propel the growth of the human embryonic stem cells market going forward. Regenerative medicine is a field of healthcare focused on repairing, replacing, or regenerating damaged tissues or organs to restore normal function in the body. There is increasing government funding for the development of regenerative medicine due to factors such as the rising prevalence of chronic diseases, advancements in stem cell research, and the potential for innovative treatments to improve patient outcomes. Human embryonic stem cells are utilized in regenerative medicine to develop potential therapies for repairing or replacing damaged tissues and organs in the body. For instance, in May 2022, according to the Government of Canada, a Canada-based body responsible for the federal administration, the stem cell network received $45 million in funding over three years, beginning in 2022-23, as part of the Budget 2021 allocation to bolster stem cell and regenerative medicine research. Therefore, government funding for the development of regenerative medicine is driving the growth of the human embryonic stem cells market. Therefore, government funding for the development of regenerative medicine is driving the growth of the human embryonic stem cells industry.

Who Are The Major Players In The Global Human Embryonic Stem Cells Market?

Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

What Are The Key Trends Of The Global Human Embryonic Stem Cells Market? Expansion Into Diverse Therapeutic Applications To Advance Regenerative Medicines

Major companies operating in the human embryonic stem cell market are focused on expanding into diverse therapeutic applications such as pluripotent stem cells for Parkinson's disease treatment, and gaining a competitive edge in the market. Pluripotent stem cells for Parkinson's disease are used to generate dopaminergic neurons, aiming to replace the lost dopamine-producing neurons and restore motor function. For instance, in October 2023, Bayer AG., a Germany-based pharmaceutical and biotechnology company, opened its first Cell Therapy Manufacturing Facility in California by investing $250 million to produce cell and gene therapies globally. This facility initially focuses on BlueRock Therapeutics' bemdaneprocel derived from pluripotent stem cells (PSC) for Parkinson's disease. The facility features fully electric manufacturing to address the industry's manufacturing capacity for regenerative medicines.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Human Embryonic Stem Cells Market? Charles River Laboratories International Collaborated With Pluristyx To Expand Stem Cell Portfolio

In February 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing, partnered with Pluristyx Inc. to enhance its portfolio with high-quality embryonic stem (ES) cells and induced pluripotent stem cells (iPSCs). This collaboration allows Charles River to distribute Pluristyx’s ES and iPS cell lines, including genetically engineered and disease state lines, supporting therapeutic development. Pluristyx Inc. is a US-based stem cell technology company that provides an extensive line of human induced pluripotent stem cells (iPSCs).

What Is The Regional Outlook For The Global Human Embryonic Stem Cells Market?

North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Embryonic Stem Cells Market?

The human embryonic stem cells market consists of sales of stem cell lines, stem cell media and reagents, and stem cell culture equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Human Embryonic Stem Cells Industry?

The human embryonic stem cells market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human embryonic stem cells industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Human Embryonic Stem Cells Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.37 billion
Revenue Forecast In 2034 $1.97 billion
Growth Rate CAGR of 9.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells
2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing
3) By Application: Research, Clinical Trials, Other Applications Subsegments: 1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells
2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells
3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Human Embryonic Stem Cells Market Characteristics

3. Human Embryonic Stem Cells Market Trends And Strategies

4. Human Embryonic Stem Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Human Embryonic Stem Cells Growth Analysis And Strategic Analysis Framework

5.1. Global Human Embryonic Stem Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Human Embryonic Stem Cells Market Growth Rate Analysis

5.4. Global Human Embryonic Stem Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Human Embryonic Stem Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Human Embryonic Stem Cells Total Addressable Market (TAM)

6. Human Embryonic Stem Cells Market Segmentation

6.1. Global Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Totipotent Stem Cells

Pluripotent Stem Cells

Unipotent Stem Cells

6.2. Global Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Regenerative Medicine

Stem Cell Biology Research

Tissue Engineering

Toxicology Testing

6.3. Global Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research

Clinical Trials

Other Applications

6.4. Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Totipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Embryonic Totipotent Stem Cells

Induced Totipotent Stem Cells

6.5. Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Embryonic Stem Cells (hESCs)

Induced Pluripotent Stem Cells (iPSCs)

Embryonic Stem Cell Lines

Conditioned Pluripotent Stem Cells

6.6. Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Unipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Somatic Stem Cells

Adult Stem Cells

Tissue-Specific Stem Cells

7. Human Embryonic Stem Cells Market Regional And Country Analysis

7.1. Global Human Embryonic Stem Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Human Embryonic Stem Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Embryonic Stem Cells Market

8.1. Asia-Pacific Human Embryonic Stem Cells Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Embryonic Stem Cells Market

9.1. China Human Embryonic Stem Cells Market Overview

9.2. China Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Embryonic Stem Cells Market

10.1. India Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Embryonic Stem Cells Market

11.1. Japan Human Embryonic Stem Cells Market Overview

11.2. Japan Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Embryonic Stem Cells Market

12.1. Australia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Embryonic Stem Cells Market

13.1. Indonesia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Embryonic Stem Cells Market

14.1. South Korea Human Embryonic Stem Cells Market Overview

14.2. South Korea Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Embryonic Stem Cells Market

15.1. Western Europe Human Embryonic Stem Cells Market Overview

15.2. Western Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Embryonic Stem Cells Market

16.1. UK Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Embryonic Stem Cells Market

17.1. Germany Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Embryonic Stem Cells Market

18.1. France Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Embryonic Stem Cells Market

19.1. Italy Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Embryonic Stem Cells Market

20.1. Spain Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Embryonic Stem Cells Market

21.1. Eastern Europe Human Embryonic Stem Cells Market Overview

21.2. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Embryonic Stem Cells Market

22.1. Russia Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Embryonic Stem Cells Market

23.1. North America Human Embryonic Stem Cells Market Overview

23.2. North America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Embryonic Stem Cells Market

24.1. USA Human Embryonic Stem Cells Market Overview

24.2. USA Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Embryonic Stem Cells Market

25.1. Canada Human Embryonic Stem Cells Market Overview

25.2. Canada Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Embryonic Stem Cells Market

26.1. South America Human Embryonic Stem Cells Market Overview

26.2. South America Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Embryonic Stem Cells Market

27.1. Brazil Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Embryonic Stem Cells Market

28.1. Middle East Human Embryonic Stem Cells Market Overview

28.2. Middle East Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Embryonic Stem Cells Market

29.1. Africa Human Embryonic Stem Cells Market Overview

29.2. Africa Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Embryonic Stem Cells Market Competitive Landscape And Company Profiles

30.1. Human Embryonic Stem Cells Market Competitive Landscape

30.2. Human Embryonic Stem Cells Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck KgaA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Embryonic Stem Cells Market Other Major And Innovative Companies

31.1. Lonza Group

31.2. PerkinElmer Inc.

31.3. R&D Systems

31.4. LifeCell

31.5. Takara Bio Inc.

31.6. ViaCyte Inc.

31.7. PromoCell GmbH

31.8. CellGenix GmbH

31.9. PeproTech Inc.

31.10. Lineage Cell Therapeutics Inc.

31.11. BioTime

31.12. Asterias Biotherapeutics Inc.

31.13. ESI BIO

31.14. STEMCELL Technologies Inc.

31.15. TATAA Biocenter

32. Global Human Embryonic Stem Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Embryonic Stem Cells Market

34. Recent Developments In The Human Embryonic Stem Cells Market

35. Human Embryonic Stem Cells Market High Potential Countries, Segments and Strategies

35.1 Human Embryonic Stem Cells Market In 2029 - Countries Offering Most New Opportunities

35.2 Human Embryonic Stem Cells Market In 2029 - Segments Offering Most New Opportunities

35.3 Human Embryonic Stem Cells Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Totipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Unipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Human Embryonic Stem Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Human Embryonic Stem Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 79: Gilead Sciences Inc. Financial Performance
  • Table 80: Merck KgaA Financial Performance
  • Table 81: Astellas Pharma Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Totipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Human Embryonic Stem Cells Market, Sub-Segmentation Of Unipotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Human Embryonic Stem Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Human Embryonic Stem Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Human Embryonic Stem Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Human Embryonic Stem Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Human Embryonic Stem Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 79: Gilead Sciences Inc. Financial Performance
  • Figure 80: Merck KgaA Financial Performance
  • Figure 81: Astellas Pharma Inc. Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Specialty Medical Chairs Global Market Report 2024 – By Product (Examination, Treatment, Rehabilitation), By Technology (Electric, Mechanical, Hydraulic, Electro-Mechanical, Other Technologies), By End User (Hospitals, C...

View Report

Cell Culture Global Market Report 2025 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tis...

View Report

Light Electric Vehicles Global Market Report 2025 – By Product (Hybrid Electric Vehicle (HEV), Plug-in Hybrid Electric Vehicle (PHEV), Battery Electric Vehicle (BEV)), By Component Type (Battery Pack, Electric motor, Mot...

View Report

Collision Avoidance System Global Market Report 2025 – By Product (Adaptive Cruise Control (ACC), Autonomous Emergency Braking (AEB), Lane Departure Warning System (LDWS), Parking Assistance, Other Products), By Technolo...

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application ...

View Report

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2025 – By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types), By Application (Academic Research, Drug Discovery...

View Report

Frequently Asked Questions

Human embryonic stem cells (hESCs) are pluripotent cells derived from the inner cell mass of a blastocyst, an early-stage embryo. These cells have the unique ability to differentiate into any cell type in the human body, making them incredibly valuable for various research and therapeutic purposes. The primary uses of hESCs includes developing treatments for diseases and injuries by generating healthy tissue and studying the progression and treatment of diseases in a controlled environment. For further insights on this market, request a sample here

The market major growth driver - Government Funding In Regenerative Medicine Is Propelling Growth Of Human Embryonic Stem Cells Market. For further insights on this market, request a sample here

The human embryonic stem cells market size has grown rapidly in recent years. It will grow from $1.24 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to funding and investments, regulatory approvals, public awareness, the emergence of regenerative medicine, and expanded clinical applications. The human embryonic stem cells market size is expected to see strong growth in the next few years. It will grow to " $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to an upsurge in several cell therapy production facilities, increasing demand for regenerative therapies, increasing incidence of cardiac and malignant diseases, advancements in stem cell biology research, and awareness about stem cell therapeutic potency. Major trends in the forecast period include advancements in regenerative medicine, increased focus on personalized medicine, growing applications in drug discovery and toxicology, technological innovations, and expansion in biobanking. For further insights on this market, request a sample here

The human embryonic stem cellsmarket covered in this report is segmented –
1) By Type: Totipotent Stem Cells; Pluripotent Stem Cells; Unipotent Stem Cells
2) By Product: Regenerative Medicine; Stem Cell Biology Research; Tissue Engineering; Toxicology Testing
3) By Application: Research; Clinical Trials; Other Applications Subsegments:
1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells; Induced Totipotent Stem Cells
2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs); Induced Pluripotent Stem Cells (iPSCs); Embryonic Stem Cell Lines; Conditioned Pluripotent Stem Cells
3) By Unipotent Stem Cells: Somatic Stem Cells; Adult Stem Cells; Tissue-Specific Stem Cells For further insights on this market, request a sample here

North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation. For further insights on this market, request a sample here.

Major trends in this market include Expansion Into Diverse Therapeutic Applications To Advance Regenerative Medicines. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Human Embryonic Stem Cells Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon